MedPath

YH-QILU Monensin 20% W/W Granule

Registration Number: MAL24046058HA

Approved
Approval ID

229aeba2fcd4d370

Registration Number

MAL24046058HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

25 kgAvailable
Package Size: 25 kg
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

MONENSIN SODIUMActive
Monograph: monensin sodium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

YH-QILU Monensin 20% W/W Granule - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform